The Value of Telemedicine for the Follow-up of Patients with New Onset Type 1 Diabetes Mellitus During COVID-19 Pandemic in Turkey: A Report of Eight Cases

The current Coronavirus disease-2019 (COVID-19) pandemic has forced health care teams to look for alternative approaches to manage a great number of children with diabetes, not only in rural but also in urban locations. The aim was to assess the provision of information about follow-up of new-onset...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ferda Evin, Eren Er, Aysun Ata, Arzu Jalilova, Günay Demir, Yasemin Atik Altınok, Samim Özen, Şükran Darcan, Damla Gökşen
Formato: article
Lenguaje:EN
Publicado: Galenos Yayincilik 2021
Materias:
Acceso en línea:https://doaj.org/article/8ea6db80154848dd937262e2e7ba4643
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8ea6db80154848dd937262e2e7ba4643
record_format dspace
spelling oai:doaj.org-article:8ea6db80154848dd937262e2e7ba46432021-11-26T06:10:17ZThe Value of Telemedicine for the Follow-up of Patients with New Onset Type 1 Diabetes Mellitus During COVID-19 Pandemic in Turkey: A Report of Eight Cases1308-57271308-573510.4274/jcrpe.galenos.2020.2020.0160https://doaj.org/article/8ea6db80154848dd937262e2e7ba46432021-12-01T00:00:00Z http://www.jcrpe.org/archives/archive-detail/article-preview/the-value-of-telemedicine-for-the-follow-up-of-pat/41648 https://doaj.org/toc/1308-5727https://doaj.org/toc/1308-5735The current Coronavirus disease-2019 (COVID-19) pandemic has forced health care teams to look for alternative approaches to manage a great number of children with diabetes, not only in rural but also in urban locations. The aim was to assess the provision of information about follow-up of new-onset pediatric type 1 diabetes (T1D) patients, and to investigate the integration of telemedicine into routine clinical care in the long term. The changes in coefficient of variation (CV), standard deviation and percentages of time in range (TIR), time below range (TBR) and time above range were evaluated in eight children with new-onset T1D, diagnosed during the COVID-19 pandemic. The study period was two-months of follow-up using a telemedicine system. Median follow-up time was 51 (24-66) days. Two of the patients were using low glucose suspend system and six were on multiple daily injection therapy. Target TIR values were achieved in seven patients in the last televisit and, in line with recent guidelines, a TBR <70 mg/dL (<3.9 mmol/L) (level 1 hypoglycemia) of <4% and a TBR <54 mg/dL (<3.0 mmol/L) (level 2 hypoglycemia) of <1% were achieved in all patients. Seven patients achieved a CV of <36% at their last televisit. Telemedicine as an alternative follow-up tool during unusual circumstances such pandemics, even in countries where it is not routinely used, could be beneficial to achieve optimum glycemic control in patients with new-onset T1D.Ferda EvinEren ErAysun AtaArzu JalilovaGünay DemirYasemin Atik AltınokSamim ÖzenŞükran DarcanDamla GökşenGalenos Yayincilikarticletype 1 diabetestelemedicinecovid-19technologysensor augmented pumpPediatricsRJ1-570Diseases of the endocrine glands. Clinical endocrinologyRC648-665ENJCRPE, Vol 13, Iss 4, Pp 468-472 (2021)
institution DOAJ
collection DOAJ
language EN
topic type 1 diabetes
telemedicine
covid-19
technology
sensor augmented pump
Pediatrics
RJ1-570
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
spellingShingle type 1 diabetes
telemedicine
covid-19
technology
sensor augmented pump
Pediatrics
RJ1-570
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
Ferda Evin
Eren Er
Aysun Ata
Arzu Jalilova
Günay Demir
Yasemin Atik Altınok
Samim Özen
Şükran Darcan
Damla Gökşen
The Value of Telemedicine for the Follow-up of Patients with New Onset Type 1 Diabetes Mellitus During COVID-19 Pandemic in Turkey: A Report of Eight Cases
description The current Coronavirus disease-2019 (COVID-19) pandemic has forced health care teams to look for alternative approaches to manage a great number of children with diabetes, not only in rural but also in urban locations. The aim was to assess the provision of information about follow-up of new-onset pediatric type 1 diabetes (T1D) patients, and to investigate the integration of telemedicine into routine clinical care in the long term. The changes in coefficient of variation (CV), standard deviation and percentages of time in range (TIR), time below range (TBR) and time above range were evaluated in eight children with new-onset T1D, diagnosed during the COVID-19 pandemic. The study period was two-months of follow-up using a telemedicine system. Median follow-up time was 51 (24-66) days. Two of the patients were using low glucose suspend system and six were on multiple daily injection therapy. Target TIR values were achieved in seven patients in the last televisit and, in line with recent guidelines, a TBR <70 mg/dL (<3.9 mmol/L) (level 1 hypoglycemia) of <4% and a TBR <54 mg/dL (<3.0 mmol/L) (level 2 hypoglycemia) of <1% were achieved in all patients. Seven patients achieved a CV of <36% at their last televisit. Telemedicine as an alternative follow-up tool during unusual circumstances such pandemics, even in countries where it is not routinely used, could be beneficial to achieve optimum glycemic control in patients with new-onset T1D.
format article
author Ferda Evin
Eren Er
Aysun Ata
Arzu Jalilova
Günay Demir
Yasemin Atik Altınok
Samim Özen
Şükran Darcan
Damla Gökşen
author_facet Ferda Evin
Eren Er
Aysun Ata
Arzu Jalilova
Günay Demir
Yasemin Atik Altınok
Samim Özen
Şükran Darcan
Damla Gökşen
author_sort Ferda Evin
title The Value of Telemedicine for the Follow-up of Patients with New Onset Type 1 Diabetes Mellitus During COVID-19 Pandemic in Turkey: A Report of Eight Cases
title_short The Value of Telemedicine for the Follow-up of Patients with New Onset Type 1 Diabetes Mellitus During COVID-19 Pandemic in Turkey: A Report of Eight Cases
title_full The Value of Telemedicine for the Follow-up of Patients with New Onset Type 1 Diabetes Mellitus During COVID-19 Pandemic in Turkey: A Report of Eight Cases
title_fullStr The Value of Telemedicine for the Follow-up of Patients with New Onset Type 1 Diabetes Mellitus During COVID-19 Pandemic in Turkey: A Report of Eight Cases
title_full_unstemmed The Value of Telemedicine for the Follow-up of Patients with New Onset Type 1 Diabetes Mellitus During COVID-19 Pandemic in Turkey: A Report of Eight Cases
title_sort value of telemedicine for the follow-up of patients with new onset type 1 diabetes mellitus during covid-19 pandemic in turkey: a report of eight cases
publisher Galenos Yayincilik
publishDate 2021
url https://doaj.org/article/8ea6db80154848dd937262e2e7ba4643
work_keys_str_mv AT ferdaevin thevalueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases
AT erener thevalueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases
AT aysunata thevalueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases
AT arzujalilova thevalueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases
AT gunaydemir thevalueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases
AT yaseminatikaltınok thevalueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases
AT samimozen thevalueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases
AT sukrandarcan thevalueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases
AT damlagoksen thevalueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases
AT ferdaevin valueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases
AT erener valueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases
AT aysunata valueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases
AT arzujalilova valueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases
AT gunaydemir valueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases
AT yaseminatikaltınok valueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases
AT samimozen valueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases
AT sukrandarcan valueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases
AT damlagoksen valueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases
_version_ 1718409792566853632